Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel
Journal cover image

Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion.

Publication ,  Journal Article
Waibl Polania, J; Hoyt-Miggelbrink, A; Tomaszewski, WH; Wachsmuth, LP; Lorrey, SJ; Wilkinson, DS; Lerner, E; Woroniecka, K; Finlay, JB ...
Published in: Immunity
January 14, 2025

Whereas terminally exhausted T (Tex_term) cells retain anti-tumor cytotoxic functions, the frequencies of stem-like progenitor-exhausted T (Tex_prog) cells better reflect immunotherapeutic responsivity. Here, we examined the intratumoral cellular interactions that govern the transition to terminal T cell exhaustion. We defined a metric reflecting the intratumoral progenitor exhaustion-to-terminal exhaustion ratio (PETER), which decreased with tumor progression in solid cancers. Single-cell analyses of Tex_prog cells and Tex_term cells in glioblastoma (GBM), a setting of severe T cell exhaustion, revealed disproportionate loss of Tex_prog cells over time. Exhaustion concentrated within tumor-specific T cell subsets, with cognate antigen exposure requisite for acquisition of the Tex_term phenotype. Tumor-associated macrophages (TAMs)-not tumor cells-were the primary source of antigenic exposure governing the Tex_prog to Tex_term transition. TAM depletion increased frequencies of Tex_prog cells in multiple tumor models, increased PETER, and promoted responsiveness to αPD1 immunotherapy. Thus, targeting TAM-T cell interactions may further license checkpoint blockade responses.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Immunity

DOI

EISSN

1097-4180

Publication Date

January 14, 2025

Volume

58

Issue

1

Start / End Page

232 / 246.e6

Location

United States

Related Subject Headings

  • Tumor-Associated Macrophages
  • Tumor Microenvironment
  • T-Lymphocytes
  • Neoplasms
  • Mice, Inbred C57BL
  • Mice
  • Immunotherapy
  • Immunology
  • Humans
  • Glioblastoma
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Waibl Polania, J., Hoyt-Miggelbrink, A., Tomaszewski, W. H., Wachsmuth, L. P., Lorrey, S. J., Wilkinson, D. S., … Fecci, P. E. (2025). Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity, 58(1), 232-246.e6. https://doi.org/10.1016/j.immuni.2024.11.026
Waibl Polania, Jessica, Alexandra Hoyt-Miggelbrink, William H. Tomaszewski, Lucas P. Wachsmuth, Selena J. Lorrey, Daniel S. Wilkinson, Emily Lerner, et al. “Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion.Immunity 58, no. 1 (January 14, 2025): 232-246.e6. https://doi.org/10.1016/j.immuni.2024.11.026.
Waibl Polania J, Hoyt-Miggelbrink A, Tomaszewski WH, Wachsmuth LP, Lorrey SJ, Wilkinson DS, et al. Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity. 2025 Jan 14;58(1):232-246.e6.
Waibl Polania, Jessica, et al. “Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion.Immunity, vol. 58, no. 1, Jan. 2025, pp. 232-246.e6. Pubmed, doi:10.1016/j.immuni.2024.11.026.
Waibl Polania J, Hoyt-Miggelbrink A, Tomaszewski WH, Wachsmuth LP, Lorrey SJ, Wilkinson DS, Lerner E, Woroniecka K, Finlay JB, Ayasoufi K, Fecci PE. Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity. 2025 Jan 14;58(1):232-246.e6.
Journal cover image

Published In

Immunity

DOI

EISSN

1097-4180

Publication Date

January 14, 2025

Volume

58

Issue

1

Start / End Page

232 / 246.e6

Location

United States

Related Subject Headings

  • Tumor-Associated Macrophages
  • Tumor Microenvironment
  • T-Lymphocytes
  • Neoplasms
  • Mice, Inbred C57BL
  • Mice
  • Immunotherapy
  • Immunology
  • Humans
  • Glioblastoma